| Literature DB >> 27571219 |
Jacob I Stuckey1, Catherine Simpson1, Jacqueline L Norris-Drouin1, Stephanie H Cholensky1, Junghyun Lee1, Ryan Pasca1, Nancy Cheng1, Bradley M Dickson1, Kenneth H Pearce1, Stephen V Frye1, Lindsey I James1.
Abstract
To better understand the contribution of methyl-lysine (Kme) binding proteins to various disease states, we recently developed and reported the discovery of 1 (UNC3866), a chemical probe that targets two families of Kme binding proteins, CBX and CDY chromodomains, with selectivity for CBX4 and -7. The discovery of 1 was enabled in part by the use of molecular dynamics simulations performed with CBX7 and its endogenous substrate. Herein, we describe the design, synthesis, and structure-activity relationship studies that led to the development of 1 and provide support for our model of CBX7-ligand recognition by examining the binding kinetics of our antagonists with CBX7 as determined by surface-plasmon resonance.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27571219 PMCID: PMC5063714 DOI: 10.1021/acs.jmedchem.6b00801
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446